SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1446179 BALA CYNWYD, PA

Back to BCRX Full portfolio

Position in BCRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$912,280

+$190,120 QoQ

Shares Held

91,228

-5.3% QoQ

Ownership

0.036%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#127

of 316 holders

Holding Since

Mar 2024

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC holds $1,979,682 across 4 Drug Manufacturers - Specialty & Generic names. BCRX ranks #1 (46.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BCRX	Biocryst Pharmaceuticals Inc This page	91,228	$912,280
2	ANIP	Ani Pharmaceuticals Inc	8,745	$723,911
3	NBIX	Neurocrine Biosciences Inc	1,422	$239,663
4	EBS	Emergent BioSolutions Inc.	12,390	$103,828

All Filings in BCRX

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$912,280	91,228	-5.3%	Shares	Sole	2026-08-14
2025-03-31	$722,160	96,288	+8.4%	Shares	Sole	2025-05-14
2024-12-31	$668,182	88,854	+194.5%	Shares	Sole	2025-02-14
2024-06-30	$186,487	30,176	-53.1%	Shares	Defined	2024-08-15
2024-03-31	$326,974	64,365	—	Shares	Defined	2024-05-07
No filing history on record for this holder in this stock.